Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study

Journal of the American Academy of Dermatology 2026 Open access

Read full text
Authors: Jennifer Soung, Yong Cui, Robert Bissonnette, Mark G. Lebwohl, Álvaro González-Cantero, Andreas Pinter, Phoebe Rich, Vimal H. Prajapati, Megan Miller-Kassamali, Joseph Cafone, Jingzhi Jiang, Shu Li
+2 more Ya-Wen Yang, Andrew Pink
DOI: 10.1016/j.jaad.2026.05.048
Cited by: 1
References: 3

Fields of Study & Subjects

Psoriasis: Treatment and Pathogenesis Hidradenitis Suppurativa and Treatments Oral Health Pathology and Treatment

Publication details

Journal / source
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Volume
95
Issue
4
Pages
1109–1112
Publication date
22 May 2026
Language
EN